8-99096433-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_152564.5(VPS13B):c.412+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_152564.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13B | NM_017890.5 | c.412+1G>T | splice_donor_variant, intron_variant | ENST00000358544.7 | NP_060360.3 | |||
VPS13B | NM_152564.5 | c.412+1G>T | splice_donor_variant, intron_variant | ENST00000357162.7 | NP_689777.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13B | ENST00000358544.7 | c.412+1G>T | splice_donor_variant, intron_variant | 1 | NM_017890.5 | ENSP00000351346.2 | ||||
VPS13B | ENST00000357162.7 | c.412+1G>T | splice_donor_variant, intron_variant | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727148
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Abnormal brain morphology Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | - | - - |
Cohen syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The homozygous c.412+1G>T variant in VPS13B was identified in our study in one individual with growth delay, intellectual disability, and microcephaly. The c.412+1G>T variant in VPS13B has been previously reported in one individual with Cohen syndrome (PMID: 26539891). This variant has also been reported in ClinVar (Variation ID: 402219) and has been interpreted as likely pathogenic by the Lupski Lab of the Baylor College of Medicine. The affected individual previously reported (PMID: 26539891) and the patient identified by our study were homozygotes for the variant, which increases the likelihood that the c.412+1G>T variant is pathogenic. A different nucleotide change that also results in a splice donor variant at the same site, c.412+1G>A has been reported likely pathogenic in ClinVar (Variation ID: 371467), and the variant being assessed here, c.412+1G>T, is predicted by SpliceAI to have a similar effect on splicing. This variant was absent from large population studies. This variant is located in the 5' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. Loss of function of the VPS13B gene is an established disease mechanism in autosomal recessive Cohen syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Cohen syndrome. ACMG/AMP Criteria applied: PVS1, PS1_Supporting, PM2_Supporting, PM3 (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at